作者：
Larson,R.A. [1]
;
Hochhaus,A. [2]
;
Hughes,T.P. [3]
;
Clark,R.E. [4]
;
Etienne,G. [5]
;
Kim,D.-W. [6]
;
Flinn,I.W. [7]
;
Kurokawa,M. [8]
;
Moiraghi,B. [9]
;
Yu,R. [10]
;
Blakesley,R.E. [11]
;
Gallagher,N.J. [12]
;
Saglio,G. [13]
;
Kantarjian,H.M.
作者单位：
Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
[1]
MD Anderson Cancer Center, University of Texas, Houston, TX, United States
[2]
Institut Bergonié, Bordeaux, France
[3]
Royal Liverpool University Hospital, Liverpool, United Kingdom
[4]
Royal Adelaide Hospital, SA Pathology, Adelaide, Australia
[5]
Novartis Pharma AG, Basel, Switzerland
[6]
University of Chicago, 5841S Maryland Avenue, MC2115, Chicago, IL 60637, United States
[7]
Seoul St Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea
[8]
Abteilung H?matologie/Onkologie, Universit?tsklinikum Jena, Jena, Germany
[9]
Sarah Cannon Research Institute, Nashville, TN, United States
[10]
University of Tokyo, Tokyo, Japan
[11]
Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina
[12]
University of Turin, Orbassano, Italy
[13]
发布时间
2013-11-20
换一批
